Class A shares of big pharmaceutical concepts rose sharply in early trading, with concepts such as CRO, recombinant protein, and innovative drugs rising among the top; Medici rose more than 16%, Bide Pharmaceutical rose more than 7%, and stocks such as Zhaoyan New Pharmaceutical, Sunshine Nuohe, and Norsig followed suit. The National Development and Reform Commission said that since the "14th Five-Year Plan", 402 new drugs have been added to the national medical insurance drug catalog.